Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammed Eslam

Showing results (71-80 of 224) with videos related to

Pageof 23
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|September 10, 2024
Dual-aetiology MAFLD and metabolic dysfunctionZiyan Pan, Gamal Shiha, Nahum Méndez-Sánchez, et al.
American Journal of Infection Control|April 20, 2010
Seroprevalence of hepatitis C and B among blood donors in Egypt: Minya Governorate, 2000-2008Mahmoud Aboelneen Khattab, Mohammed Eslam, Mohammed Ahmed Sharwae, et al.
Frontiers in Bioscience (Landmark Edition)|April 29, 2024
A Cell Specific Effect of MBOAT7 MAFLD-risk Variant on Immune CellsZiyan Pan, Jawaher Alharthi, Ali Bayoumi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 3, 2024
The MAFLD definition identifies three homogenous groups of patientsZiyan Pan, Yusuf Yilmaz, Said A Al-Busafi, et al.
Hepatobiliary Surgery and Nutrition|December 10, 2020
When a new definition overhauls perceptions of MAFLD related cirrhosis careKenneth I Zheng, Mohammed Eslam, Jacob George, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 26, 2021
Development of a simple dynamic algorithm for individualized hepatocellular carcinoma risk-based surveillance using pre- and post-treatment general evaluation scoreGamal Shiha, Reham Soliman, Nabiel Mikhail, et al.
Plos One|May 9, 2024
Exportin 4 DNA promoter methylation in liver fibrosisZiyan Pan, Ali Bayoumi, Mayada Metwally, et al.
Journal of Digestive Diseases|December 13, 2021
The importance and impact of recognizing metabolic dysfunction-associated fatty liver disease in patients with chronic hepatitis CAhmed Al-Omary, Karen Byth, Martin Weltman, et al.
Current Opinion in Gastroenterology|February 10, 2022
Metabolic dysfunction-associated fatty liver disease: a year in reviewJawaher Alharthi, Amalia Gastaldelli, Ian Homer Cua, et al.
Hepatology International|June 20, 2024
Telomere length and mortality in lean MAFLD: the other face of metabolic adaptationMohammad Alarabi, Ziyan Pan, Manuel Romero-Gómez, et al.
Pageof 23

Showing results (71-80 of 224) with videos related to

Sort By:
Pageof 23
Liver International : Official Journal of the International Association for the Study of the Liver|September 10, 2024
Dual-aetiology MAFLD and metabolic dysfunctionZiyan Pan, Gamal Shiha, Nahum Méndez-Sánchez, et al.
American Journal of Infection Control|April 20, 2010
Seroprevalence of hepatitis C and B among blood donors in Egypt: Minya Governorate, 2000-2008Mahmoud Aboelneen Khattab, Mohammed Eslam, Mohammed Ahmed Sharwae, et al.
Frontiers in Bioscience (Landmark Edition)|April 29, 2024
A Cell Specific Effect of MBOAT7 MAFLD-risk Variant on Immune CellsZiyan Pan, Jawaher Alharthi, Ali Bayoumi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 3, 2024
The MAFLD definition identifies three homogenous groups of patientsZiyan Pan, Yusuf Yilmaz, Said A Al-Busafi, et al.
Hepatobiliary Surgery and Nutrition|December 10, 2020
When a new definition overhauls perceptions of MAFLD related cirrhosis careKenneth I Zheng, Mohammed Eslam, Jacob George, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 26, 2021
Development of a simple dynamic algorithm for individualized hepatocellular carcinoma risk-based surveillance using pre- and post-treatment general evaluation scoreGamal Shiha, Reham Soliman, Nabiel Mikhail, et al.
Plos One|May 9, 2024
Exportin 4 DNA promoter methylation in liver fibrosisZiyan Pan, Ali Bayoumi, Mayada Metwally, et al.
Journal of Digestive Diseases|December 13, 2021
The importance and impact of recognizing metabolic dysfunction-associated fatty liver disease in patients with chronic hepatitis CAhmed Al-Omary, Karen Byth, Martin Weltman, et al.
Current Opinion in Gastroenterology|February 10, 2022
Metabolic dysfunction-associated fatty liver disease: a year in reviewJawaher Alharthi, Amalia Gastaldelli, Ian Homer Cua, et al.
Hepatology International|June 20, 2024
Telomere length and mortality in lean MAFLD: the other face of metabolic adaptationMohammad Alarabi, Ziyan Pan, Manuel Romero-Gómez, et al.
Pageof 23